Microsoft Earnings Show Azure Growth and Heavy Capex

Microsoft earnings on Oct. 28, 2026 highlighted Azure and Cloud expansion and stepped-up capex that tightened free cash flow and refocused traders.

October 29, 2026·2 min read
View all news articles
Flat-vector cover of a server cluster under heavy load symbolizing Microsoft earnings focus on Azure growth and capex.

KEY TAKEAWAYS

  • Azure revenue rose 48.0% to $33.2 billion, underlining Azure and Microsoft Cloud momentum.
  • Capital expenditures and finance leases totaled $45.2 billion, signaling stepped-up AI capacity investment.
  • Free cash flow fell 27.0% to $18.6 billion, tightening near-term cash flexibility.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Microsoft Corp. (MSFT) reported fiscal first-quarter 2027 results on Oct. 28, 2026, highlighting rapid Azure and Microsoft Cloud expansion alongside increased capital spending to build AI capacity. The company’s strong growth outlook contrasts with near-term pressure on cash flow.

Azure and Cloud Growth

Microsoft posted revenue of $92.3 billion for the quarter ended Sept. 30, 2026, a 19% increase year over year. Microsoft Cloud revenue rose 30% to $63.9 billion, while Azure revenue climbed 48% to $33.2 billion. The company defines Azure revenue as including cloud- and AI consumption-based services and virtual-desktop offerings.

Earnings, Cash Flow, and Investment

Operating income reached $45.9 billion, with GAAP net income of $36.6 billion and diluted GAAP earnings per share of $4.92. On a non-GAAP basis, net income was $36.4 billion with adjusted diluted EPS of $4.89. The company returned $10.2 billion to shareholders through dividends and share repurchases during the quarter.

Capital expenditures and finance leases totaled $45.2 billion, about 30% higher than a year earlier. Cash paid for property and equipment was approximately $39.4 billion, with roughly three-quarters spent on short-lived assets such as processors and graphics-processing units. Free cash flow declined 27% year over year to $18.6 billion.

Chief Financial Officer Amy Hood projected fiscal second-quarter Azure growth of about 49%–50% on a constant-currency basis and said capital spending would exceed $50 billion. The company indicated roughly $170 billion of capacity investment for calendar 2027 to meet demand and disclosed delays in some third-party capacity deliveries.

These results illustrate a trade-off: strong Azure and Microsoft Cloud growth supports a long-term AI-driven expansion, while increased capacity investment weighs on near-term cash generation and financial flexibility.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Stryker Earnings Miss, Lowers Full Year Outlook

Stryker Earnings Miss, Lowers Full Year Outlook

Stryker third-quarter earnings missed and the company cut full-year sales and EPS guidance, pressuring shares and heightening near-term execution risk.

Amazon Intel Reddit Earnings: AI and Capex

Amazon Intel Reddit Earnings: AI and Capex

Amazon Intel Reddit earnings showed AWS and Intel AI revenue gains while Amazon's $220.0B capex plan and mixed guidance shifted near-term tech positioning.

ExxonMobil Q3 Earnings Top Estimates on Refining Surge

ExxonMobil Q3 Earnings Top Estimates on Refining Surge

ExxonMobil Q3 earnings rose as stronger refining margins lifted adjusted profit and cash flow, supporting big distributions and a $20B 2027 repurchase plan.

Alphabet Q3 2026 Earnings Miss Estimates

Alphabet Q3 2026 Earnings Miss Estimates

Alphabet Q3 2026 earnings showed Cloud strength but EPS missed as $51.4 billion capex drove free cash flow negative and heightened doubts about AI returns.

BP Q3 Profit Soars; Warns Of Weaker Q4 Trading

BP Q3 Profit Soars; Warns Of Weaker Q4 Trading

BP Q3 profit jumped on refining margins and trading; strong cash flow cut net debt, but management warned Q4 trading is typically weaker.

AstraZeneca Q3 Results Highlight Oncology-Led Momentum

AstraZeneca Q3 Results Highlight Oncology-Led Momentum

AstraZeneca Q3 results showed stronger revenue and core EPS and cited late-stage readouts and approvals on Oct. 30, 2026, refining investor positioning.